Chien-Yu Cheng

14PUBLICATIONS
54CO-AUTHORS
PharmacogenomicsMedical virologyGenome structure and regulationNanotoxicology, health and safetyBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 01, 2026
Direct Initiation of Long-Acting Cabotegravir Plus Rilpivirine in People with HIV and Suboptimal Virologic Suppression: A Randomized Trial.

|Aug 08, 2025
Concordance of Oral and Anal Human Papillomavirus in Men Who Have Sex With Men Living With Human Immunodeficiency Virus.

Po-Chi Huang, Szu-I Lin, Na-Lee Sun

|Feb 12, 2025
Prevalence of Naturally Occurring HIV-1 Capsid Inhibitor Resistance-Related Mutations in Antiretroviral Therapy-Naïve and -Experienced Individuals in Taiwan.

Nan-Yu Chen, Chien-Yu Cheng, Shih-Hao Lo

|Dec 31, 2024
Oncogenic human papillomavirus and anal microbiota in men who have sex with men and are living with HIV in Northern Taiwan.

Shu-Hsing Cheng, Yu-Chen Yang, Cheng-Pin Chen

|Nov 29, 2024
Safety, tolerability, and efficacy of intranasally-administered detoxified LTh(αK) in mild-to-moderate COVID-19 patients: A randomized, double-blinded, placebo-controlled phase 2 study.

Chien-Yu Cheng, Ying-Shih Su, Chyi-Liang Chen

|Nov 20, 2024
Assessment of risk factors for virological nonsuppression following switch to dolutegravir and lamivudine, or bictegravir, emtricitabine, and tenofovir alafenamide fumarate in a real-world cohort of treatment-experienced adults living with HIV.

Shu-Yuan Lee, Yi-Chun Lin, Cheng-Pin Chen

Pageof 3

Frequent Collaborators

6 joint publications

Cheng-Pin Chen

6 joint publications

Shu-Hsing Cheng

3 joint publications

Shin-Ru Shih

2 joint publications

Kuan-Ying A Huang